Wednesday, July 03, 2024 11:00:48 AM
The growth and prospects should truly command a higher share price. I don't fully understand all of the tactics of manipulation. Dark pools are especially troublesome where it appears transactions can be parked for later use. This completely destroys the supply/demand thesis. I have read how the algorithms play on the emotions of retail. That is how it feels right now where the price can never seem to break $70. The algorithms are designed to get people to capitulate.
I don't have data, but it always seems like the share price is attacked prior to earnings to accumulate shares. I will look at this to see if there is not a trading strategy that could be deployed.
I don't have data, but it always seems like the share price is attacked prior to earnings to accumulate shares. I will look at this to see if there is not a trading strategy that could be deployed.
Recent ANIP News
- ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/27/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 08:13:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:16:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 03:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 12:27:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 10:34:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 08:51:01 PM
- ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlook • IH Market News • 05/08/2026 01:45:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 10:58:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 10:56:34 AM
- ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance • GlobeNewswire Inc. • 05/08/2026 10:50:00 AM
- ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET • GlobeNewswire Inc. • 04/24/2026 10:50:00 AM
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity • GlobeNewswire Inc. • 04/20/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:40:36 PM
- ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules • IH Market News • 04/13/2026 03:12:39 PM
- ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules • GlobeNewswire Inc. • 04/13/2026 10:50:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:14:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:13:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:12:05 PM
- ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet • GlobeNewswire Inc. • 04/08/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:21:22 PM
- ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology • GlobeNewswire Inc. • 04/07/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:48 PM
